followers 0 popularity
6
following 1

following  view all

Groups
mansi123 is not in any groups
mansi123

US Inhaler Market Trends, Size, Competitive Analysis and Forecast - 2019-2025.

Feb 13th 2020 at 3:58 AM

US inhaler market is anticipated to grow at a substantial rate of 1.3% during the forecast period. The growth of the market of inhaler devices in the US is mainly driven by factors which include the growing prevalence of chronic diseases such as asthma, diabetes, respiratory lung diseases and so on. Asthma is chronic inflammation of the lung airways that causes breathlessness and coughing. The number of people with asthma grows every year in the US. According to CDC, there are around 26 million asthma patients in the US, among which, nearly 18.9 million are adults and 7.1 million are children. Moreover, the prevalence of asthma in children is nearly 9.4% which is higher than that of adults accounting to around 7.7%, and higher in females nearly 9.2% than in males accounting to 7% of total asthma patients. This is one of the primary reasons for the high growth rate of the market within the country.

Request a Free Sample of our Report on US Inhaler Market: https://www.omrglobal.com/request-sample/us-inhaler-market

The US inhaler market is segmented on the basis of device, type, application, and end-user. On the basis of device, the market is sub-segmented into metered dosed inhaler, dry powdered inhaler, and nebulizer. The dry powder inhaler is estimated to have largest market share in the US inhaler market due to providing easy inhalation solution. Whereas, the market for metered dose inhaler is estimated to be the fastest growing at a CAGR during the forecast period owing to innovations and collaborations by the companies for the development of metered dosed inhaler. Based on the type, preventive, reliever, and long acting bronchodilators inhaler are analyzed. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

A full Report of US Inhaler Market is Available at: https://www.omrglobal.com/industry-reports/us-inhaler-market

US Inhaler Market Segmentation

By Device

  • Metered Dose Inhaler
  • Dry Powder Inhaler
  • Nebulizer

By Type

  • Preventive Inhaler
  • Reliever Inhaler
  • Long Acting Bronchodilators Inhaler

By Application

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • US Inhaler Market by End-User
  • Homecare
  • Hospitals and Clinics

Company Profiles

  • 3M Co.
  • Acorda Therapeutics, Inc.
  • Adamis Pharmaceuticals Corp.
  • Adherium Ltd.
  • Aradigm Corp.
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Drive Devilbiss Healthcare LLC
  • GlaxoSmithKline PLC
  • Koninklijke Philips N.V.
  • Manta Devices LLC
  • Novartis AG
  • Omron Healthcare Inc.
  • ResMed Corp.
  • Pulmatrix Inc.
  • Savara, Inc.
  • Sunovion Pharmaceuticals
  • Teva Pharmaceuticals Industries Ltd.

 

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-inhaler-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

 

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +1 646-755-7667, +91 7803040404

0 comments
Please to comment

sign in

Username
Password
Remember Me


New to IM faceplate? join free!

Lost Password? click here